Development of unique nutraceutical formulations. Submission to Health Canada for Natural Health Product Numbers (NPN)
Completion of Facility to the Controlled Drugs and Substances Act (CDSA) specifications prior to inspection by Health Canada.
Sunshine Labs issued a Dealer’s License (DL) for Psilocybin under Health Canada’s Controlled Drugs and Substances Act (CDSA)
Commencement of Good Manufacturing Practices (GMP) facility modifications. Quality Assurance (QA) manager joins Sunshine Labs.
Launch the corporate website and develop e-commerce infrastructure.
Health Canada approves Sunshine Lab’s unique NPN formulations.
License amended by Health Canada to include MDMA production and distribution.
Health Canada approves Coca Leaf & Cocaine in the Controlled Substances Dealer's License.
GMP build-out in process.
Nutraceutical Vertical under construction.